Merck signals beyond the news: 53+ signals from 6 sources
The latest Merck signal on this page is from Sep 29, 2026 (Patents): "Merck Sharp & Dohme's patent output is steady: 1 grant in the past year, 1 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and X (Twitter) (12).
- Signals
- 53+
- Sources
- 6
- Last 90 days
- 47
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Merck signals by source
53+ signals for Merck across 6 sources.
Patents · Patent pace
Merck Sharp & Dohme's patent output is steady: 1 grant in the past year, 1 in the past 30 days.
Over the past year Merck Sharp & Dohme received 1 US patent grant; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 1
- Grants, 90 days
- 1
- Grants, 30 days
- 1
- USPTO assignee
- Merck Sharp & Dohme
Reddit · Customer feedback
A Reddit user describes Merck's interview process as the 'slowest and worst', noting that it frequently results in a rejection for the candidate.
Post: "Which company has you thinking this?"
- Subreddit
- r/biotech
- Upvotes
- 846
- Comments
- 68
- Sentiment
- Negative
Reddit · Customer feedback
Merck receives mixed reviews as an employer for Clinical Research Associates, with some commenters praising its great benefits, pension plan, and good work-life balance, while another described it...
Post: "CRA for Merck or AbbVie?"
- Subreddit
- r/clinicalresearch
- Upvotes
- 6
- Comments
- 22
- Sentiment
- Mixed
Patents · Patent grant
Merck Sharp & Dohme was granted a patent for nitrosamine testing.
In September 2026 Merck Sharp & Dohme patented a rapid quality-control method for detecting trace nitrosamines in solid pharmaceutical samples.
- Patent title
- Method for analyzing trace levels of semi-volatile nitrosamines in solid samples
- Grant date
- Sep 8, 2026
- Inventors
- Rebecca Evans, Xinxin Han, Daniel E. Lee, Christine L. Radich
Glassdoor · Growth opportunities
Limited career growth and progression opportunities mentioned in two reviews
An Associate Software Engineer and a Business Analyst both reported that career progression and mobility, particularly international opportunities, are limited and dependent on available openings.
- Overall rating
- 4.1 of 5
- CEO approval
- 83%
- Reviews read
- 10
- Review window
- Aug 23, 2026 to Sep 4, 2026
Glassdoor · Poor work life balance
High pressure environment with poor work life balance cited by one employee
A Medical Science Liaison reported a very high-pressure environment and poor work-life balance despite competitive pay and benefits, specifically mentioning the need for better balance.
- Overall rating
- 4.1 of 5
- CEO approval
- 83%
- Reviews read
- 10
- Review window
- Aug 23, 2026 to Sep 4, 2026
X (Twitter)
Merck and Moderna announce positive Phase 3 results for individualized neoantigen therapy in melanoma.
In collaboration with @moderna_tx, we’re excited to share the first positive Phase 3 topline results for our investigational individualized neoantigen therapy (INT) in combination with our company’s immunotherapy in the adjuvant setting for certain patients with completely resected stage IIB-IV #melanoma...
- Account
- @Merck
- Views
- 38,871
- Likes
- 184
- Reposts
- 54
Website changes · Customer win
Merck highlighted key regulatory and clinical milestones across its broad, diverse pipeline.
Added news release: “Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline.”
- Page
- /media
X (Twitter)
Merck announces FDA acceptance of its filing related to RSV disease.
We’re pleased to announce the FDA has accepted our filing related to #RSV disease. Learn more: https://t.co/DynIWTtyIK https://t.co/cxaoJ0No8j
- Account
- @Merck
- Views
- 7,190
- Likes
- 36
- Reposts
- 4
Podcasts · Customer experience focus
One Day in Transformation discusses Merck: customer experience focus
"They're looking at their business and saying, what patients are we leaving behind and why? and really making sure that they're understanding that and studying that and doing things about it."
- Podcast
- One Day in Transformation
- Episode
- Celeste Warren: Why Equity Is a Business Imperative, Not a Trend
- Speaker
- Celeste Warren
- Speaker role
- Third party
Showing 10 of 53+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Merck with the Signal API
One POST /v1/companies/enrich call with merck.com returns Merck signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "merck.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Merck other signals
What signals does Autobound track for Merck besides news and filings?
What are people saying about Merck online?
What do employees say about working at Merck?
Has Merck been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .